J Gastroenterol Hepatol. 2005 Dec;20(12):1807-16.

Liver support systems: promise and reality.

Source

South Australian Liver Transplantation Unit, Flinders Medical Center, Adelaide, South Australia, Australia. alan.wigg@flinders.edu.au

Abstract

Effective liver support is needed for a variety of indications. A large number of both biological (containing hepatocytes) and non-biological extracorporeal liver support systems have been described in the literature over the last 50 years. Despite this, there is a paucity of good quality randomized control data examining the effectiveness of these therapies in human liver failure. In this review article, we examine the available data, with particular emphasis on the current front runners, the MARS and HepatAssist systems. Other problems associated with the development of these liver support systems are also discussed. Although promising in animal studies, we conclude that the use of these technologies is not supported currently by a sufficient evidence base to recommend them for routine clinical use and that a lack of understanding about the critical functions required of a liver support system is retarding a more rational approach to the design of these systems.

PMID:: 16336437; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

Serum Albumin

LinkOut - more resources

Full Text Sources

Other Literature Sources

Labome Researcher Resource - ExactAntigen/Labome

Supplemental Content

Related citations

Review Hepatocyte culture systems for artificial liver support: implications for critical care medicine (bioartificial liver support). [Crit Care Med. 1992]
Review Hepatocyte culture systems for artificial liver support: implications for critical care medicine (bioartificial liver support).
Nyberg SL, Shatford RA, Hu WS, Payne WD, Cerra FB. Crit Care Med. 1992 Aug; 20(8):1157-68.
Review Liver support technology--an update. [Xenotransplantation. 2006]
Review Liver support technology--an update.
Rozga J. Xenotransplantation. 2006 Sep; 13(5):380-9.
Review Bioartificial liver systems: current status and future perspective. [J Biosci Bioeng. 2005]
Review Bioartificial liver systems: current status and future perspective.
Park JK, Lee DH. J Biosci Bioeng. 2005 Apr; 99(4):311-9.
Bioartificial liver: current status. [Transplant Proc. 2005]
Bioartificial liver: current status.
Pless G, Sauer IM. Transplant Proc. 2005 Nov; 37(9):3893-5.
Review [Current benefit of biological and non-biological methods in the treatment of acute liver failure]. [Rozhl Chir. 2008]
Review [Current benefit of biological and non-biological methods in the treatment of acute liver failure].
Ryska O, Pantoflícek T, Lásziková E, Prazák J, Ryska M. Rozhl Chir. 2008 Jun; 87(6):291-6.

See reviews... See all...

Cited by 1 PubMed Central article

Future of bioartificial liver support. [World J Gastrointest Surg. 2009]
Future of bioartificial liver support.
Chamuleau RA. World J Gastrointest Surg. 2009 Nov 30; 1(1):21-5.

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Liver support systems: promise and reality.
Liver support systems: promise and reality.
J Gastroenterol Hepatol. 2005 Dec ;20(12):1807-16.

PubMed
Defining the human deubiquitinating enzyme interaction landscape.
Defining the human deubiquitinating enzyme interaction landscape.
Cell. 2009 Jul 23 ;138(2):389-403. Epub 2009 Jul 16 .

PubMed
Clinical variability in distal spinal muscular atrophy type 1 (DSMA1): determina...
Clinical variability in distal spinal muscular atrophy type 1 (DSMA1): determination of steady-state IGHMBP2 protein levels in five patients with infantile and juvenile disease.
J Mol Med (Berl). 2009 Jan ;87(1):31-41. Epub 2008 Sep 18 .

PubMed
Accelerated resolution of laser-induced bruising with topical 20% arnica: a rate...
Accelerated resolution of laser-induced bruising with topical 20% arnica: a rater-blinded randomized controlled trial.
Br J Dermatol. 2010 Sep ;163(3):557-63. doi: 10.1111/j.1365-2133.2010.09813.x.

PubMed
Yoga for depression: the research evidence.
Yoga for depression: the research evidence.
J Affect Disord. 2005 Dec ;89(1-3):13-24. Epub 2005 Sep 26 .

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: